Search Results 31-40 of 866 for 硅pu最新标准,肇庆轻钢厂家,河源活动板房厂家,广东钢格板生产厂家,广东石墨厂家等欢迎访问体育百科官方网站:www.ty.gs

  1. Laboratories - Mayo Clinic Research

    Sort by: Faculty · Areas of Research · Find a program led by a researcher whose last name begins with the letter A A · Find a program led by a researcher ...

  2. https://www.mayoclinic.org/spanish_patient_consumer_faq.xml

  3. https://www.mayoclinic.org/patient_consumer_faq.xml

  4. Cancer Treatment! Clinical Trials - Mayo Clinic Research

    The purpose of this long-term data collection of patients with benign or malignant hematologic diseases is to collect patient demographics, disease ...

  5. PTT-936, An Alpha Kinase 1 (ALPK1) Activator, Alone Or In Combination With Anti-PD-1/L1 In Patients With Locally Advanced Or Metastatic Solid Tumors - Mayo Clinic

    About this study. The primary objective of this study is to evaluate the safety and tolerability of a pharmacologically active dose (PAD) range of PTT-936, ...

  6. GME Faculty Recognized for Teaching Excellence - News Archive - Mayo Clinic College of Medicine & Science

    Presented by the Mayo Fellows' Association, more than 64 faculty members were honored as Teacher of the Year.

  7. Patents - Infectious Diseases Lab - Mayo Clinic Research

    Investigator, Patent Title, Patent Number, Patent Date. Robin Patel, M.D., Detection of Bordetella, U.S. No. 7,691,571, Jan. 9, 2004.

  8. Yuguang Liu, Ph.D. - Mayo Clinic Faculty Profiles

    Mayo Clinic researcher Yuguang Liu, Ph.D., focuses on how microscale abnormalities lead to diseases. She is also developing microfluidic technologies to ...

  9. A Phase 1/2 Study Of CYT-0851 In B-Cell Malignancies And Advanced Solid Tumors - Mayo Clinic

    About this study. The purpose of this study is to assess the safety, tolerability and pharmacokinetics (PK) of CYT-0851 in patients with relapsed/refractory ...

  10. Overview - Biomaterials and Regenerative Medicine Laboratory - Mayo Clinic Research

    Dr. Lichun Lu's Biomaterials and Regenerative Medicine Lab at Mayo Clinic develops biomimetic polymer-based therapies for tissue engineering and drug ...